Brainomix touts e-Lung software clinical study results
U.K. AI software developer Brainomix highlighted a study that shows its e-Lung automated CT processing algorithm can stratify patients at risk of idiopathic pulmonary fibrosis.
U.K. AI software developer Brainomix highlighted a study that shows its e-Lung automated CT processing algorithm can stratify patients at risk of idiopathic pulmonary fibrosis.
Smart health systems empower doctors to give patients the knowledge they need to take preventive health action. Learn more with the AMA.
New rules could demystify rapid-fire disclaimers at the end of TV and radio ads.
For many, this long weekend marks the beginning of summer, with beaches and lakes welcoming crowds for safe swimming, barbeques bringing friends together, and…
SCREEN FOR DIABETES DISTRESS AND ADDRESS SPECIFIC CAUSES | INSTITUTE A “CODE WHITE” PROTOCOL FOR WORKPLACE VIOLENCE | MAKE EMPATHY SUSTAINABLE
Industrial applications of microbial electrochemical systems will require regular maintenance shutdowns, involving inspections and component replacements to extend the lifespan of the system. Here, we…
Japanese drugmaker Nippon Shinyaku said that its Duchenne muscular dystrophy drug, Viltepso, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial.
A phase 2b dose-finding study suggests use of clazakizumab was associated with a reduction in hs-CRP among patients undergoing maintenance dialysis.
The Royal College of Radiologists (RCR) has responded to a U.K. Parliamentary question tabled by the Shadow Secretary of State for Health and Social Care…
Japanese drugmaker Nippon Shinyaku said that its Duchenne muscular dystrophy drug, Viltepso, had failed to reach its primary endpoint in a placebo-controlled confirmatory trial.
Communications Earth & Environment – Wildfire smoke reduced shortwave radiation fluxes and rates of primary production and ecosystem respiration in lakes, though responses varied among…